Novel insulin-like growth factor-methotrexate covalent conjugate inhibits tumor growth in vivo at lower dosage than methotrexate alone (Q39850815)

15 September 2017

title

Novel insulin-like growth factor-methotrexate covalent conjugate inhibits tumor growth in vivo at lower dosage than methotrexate alone (English)

1 reference

15 September 2017

1 reference

Hugh McTavish

1

1 reference

15 September 2017

Robert J Griffin

series ordinal

2

1 reference

15 September 2017

Kaoru Terai

series ordinal

3

1 reference

15 September 2017

Arkadiusz Z Dudek

series ordinal

4

1 reference

15 September 2017

publication date

14 March 2009

1 reference

15 September 2017

published in

Translational Research

1 reference

15 September 2017

volume

153

1 reference

15 September 2017

issue

6

1 reference

15 September 2017

page(s)

275-282

1 reference

Disrupting insulin-like growth factor signaling as a potential cancer therapy

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2009.02.005

The insulin-like growth factor pathway in lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2009.02.005

DNA copy number changes and evaluation of MYC, IGF1R, and FES amplification in xenografts of pancreatic adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2009.02.005

Function of the IGF-I receptor in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2009.02.005

Expression of insulin-like growth factor-1 receptor in human colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2009.02.005

Characterization of insulin-like growth factor I receptors and growth effects in human lung cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2009.02.005

Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2009.02.005

Insulin effects on methotrexate polyglutamate synthesis and enzyme binding in cultured human breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2009.02.005

Expression of the insulin-like growth factor-1 receptor and its anti-apoptotic effect in malignant melanoma: a potential therapeutic target.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2009.02.005

Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2009.02.005

The role of circulating IGF-I: lessons from human and animal models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2009.02.005

Insulin-like growth factor-I receptor internalization regulates signaling via the Shc/mitogen-activated protein kinase pathway, but not the insulin receptor substrate-1 pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2009.02.005

Receptor-mediated endocytosis and lysosomal processing of insulin-like growth factor I by mitogenically responsive cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2009.02.005

Insulin receptor internalization: molecular mechanisms and physiopathological implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2009.02.005

Novel recombinant fusion protein analogues of insulin-like growth factor (IGF)-I indicate the relative importance of IGF-binding protein and receptor binding for enhanced biological potency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2009.02.005

Insulin-Like Growth Factor I (IGF-I) and IGF Binding Protein-1 Modulate Prostate Cancer Cell Growth and Apoptosis: Possible Mediators for the Effects of Diet and Exercise on Cancer Cell Survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2009.02.005

Anabolic effects of insulin-like growth factor-I (IGF-I) and an IGF-I variant in normal female rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2009.02.005

HER receptor signaling confers resistance to the insulin-like growth factor-I receptor inhibitor, BMS-536924.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2009.02.005

Substrate competitive inhibitors of IGF-1 receptor kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2009.02.005

Development of new insulin-like growth factor-1 receptor kinase inhibitors using catechol mimics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2009.02.005

Cyclolignans as inhibitors of the insulin-like growth factor-1 receptor and malignant cell growth.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2009.02.005

Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2009.02.005

Phase I, pharmacokinetic and pharmacodynamic study of the anti-insulinlike growth factor type 1 Receptor monoclonal antibody CP-751,871 in patients with multiple myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2009.02.005

Phase I dose escalation study of the anti insulin-like growth factor-I receptor monoclonal antibody CP-751,871 in patients with refractory solid tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2009.02.005

Combination therapy enhances the inhibition of tumor growth with the fully human anti-type 1 insulin-like growth factor receptor monoclonal antibody CP-751,871.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2009.02.005

Insulin-like growth factor (IGF) system components in human prostatic cancer cell-lines: LNCaP, DU145, and PC-3 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2009.02.005

The insulin-like growth factor system as a target in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2009.02.005

In vivo antitumor activity of NVP-AEW541-A novel, potent, and selective inhibitor of the IGF-IR kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2009.02.005

Down-regulation of insulin-like growth factor I receptor activity by NVP-AEW541 has an antitumor effect on neuroblastoma cells in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2009.02.005

10.1016/J.TRSL.2009.02.005

7 January 2021

Identifiers

DOI

1 reference

15 September 2017

1 reference